Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06030206 · ClinicalTrials.gov registry record · NA
Lung Transplant READY CF 2: A Multi-site RCT
A NA study of Cystic Fibrosis, sponsored by University of Washington.
- Active
- Registry status
- NA
- Development phase
- 132
- Enrollment target
- 11
- Study locations
NCT06030206 is a NA study of Cystic Fibrosis that is active but no longer recruiting, run by University of Washington. The registered enrollment target is 132 participants, below the 178-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (26% lower). The trial reports 11 study locations across 11 states.
The verdict
NCT06030206, a NA study of Cystic Fibrosis, is active but no longer recruiting, sponsored by University of Washington.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 132 participants
- Enrollment target
- 11
- Study locations
Study Summary
Lung transplant is an option for treating end-stage lung disease in cystic fibrosis (CF). In the United States, more people with CF and low lung function die each year than undergo lung transplant. More than half of people with CF who die without a lung transplant were never referred for consideration. Patient preference not to undergo lung transplant may account for 25-40% of decisions to defer referral. Rates of death without transplant are higher for people with CF who are members of marginalized communities, including those with Black race, Hispanic ethnicity, or low socioeconomic status. Increasing awareness of lung transplant among people with CF, and promoting understanding of the risks and benefits of transplant, can potentially reduce the number of people with CF who die without a lung transplant. The CF Foundation (CFF) lung transplant referral guidelines were developed to optimize the timing of referral for lung transplant. These guidelines recommend annual conversations with people with CF once their forced expiratory volume in one second (FEV1) is \<50% predicted. Considering lung transplant as a treatment option before it is medically needed will allow more time to learn about lung transplant and address any barriers to lung transplant that may exist. Investigators are interested in understanding how people with CF use lung transplant educational resources and how one prepares for having discussions and/or making decisions about lung transplant as a treatment option for advanced CF. The purpose of this study is to test whether a research website improves patient preparedness for discussions about lung transplant. Investigators also aim to understand whether there are unique factors that affect people with CF from communities with decreased access to transplant ("communities of concern"). Study involvement will span 6 months and study activities will involve the following: * Four Zoom research sessions (15-30 minutes each) * Survey assessments * Acc
Conditions Studied
Interventions
- BEHAVIORAL Investigator-designed lung transplant education resource (Research Intervention)
- BEHAVIORAL Publicly available transplant education resource (Attention-control)
Study Locations (11)
California
- University of California at Los Angeles (UCLA) - Los Angeles
Colorado
- National Jewish Health - Denver
Connecticut
- Yale University - New Haven
Kansas
- University of Kansas - Kansas City
Maine
- Maine Health - Portland
Maryland
- Johns Hopkins University - Baltimore
Minnesota
- University of Minnesota - Minneapolis
Ohio
- University of Cincinnati - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2023-09-06 |
| Est. Completion | 2027-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06030206
The ClinicalTrials.gov registry entry for NCT06030206 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 178-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (26% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cystic Fibrosis appearing as the primary indexed condition, and to 2 interventions - of which Investigator-designed lung transplant education resource (Research Intervention) is the first listed.
NCT06030206 reports 11 study locations spanning 11 distinct geographic areas - top geographies include California, Colorado, Connecticut.
Frequently Asked Questions
What is clinical trial NCT06030206 about?
NCT06030206 is a clinical study titled "Lung Transplant READY CF 2: A Multi-site RCT". Lung transplant is an option for treating end-stage lung disease in cystic fibrosis (CF). In the United States, more people with CF and low lung function die each year than undergo lung transplant. More than half of people with CF who die without a lung transplant were never referred for considerati...
What is the current status of trial NCT06030206?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 132 participants. The study started on 2023-09-06. Estimated completion is 2027-05-31.
What conditions does trial NCT06030206 study?
This clinical trial studies the following conditions: Cystic Fibrosis.
What interventions are being tested in trial NCT06030206?
The interventions under investigation include: Investigator-designed lung transplant education resource (Research Intervention) (BEHAVIORAL), Publicly available transplant education resource (Attention-control) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06030206?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06030206 being conducted?
This trial has 11 study locations across California, Colorado, Connecticut, Kansas, Maine. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cystic Fibrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exercise in Child Health
RECRUITING · NA
-
A Pilot and Feasibility Study to Evaluate High vs Low Glycemic Index Mixed Meal Tolerance Test in Adolescents and Young Adults With Cystic Fibrosis
RECRUITING · NA
-
FEED-Cystic Fibrosis (FEED-CF)
RECRUITING · NA
-
The Effects of a Low Glycemic Load Diet on Dysglycemia and Body Composition in Adults With Cystic Fibrosis-Related Diabetes
RECRUITING · NA
-
Skin-interfaced Colorimetric Bifluidic Sweat Sensor Device for the Diagnosis of Cystic Fibrosis (CF)
RECRUITING · NA
-
Lung Transplant READY CF 2: CARING CF Ancillary RCT
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.